SCOPUS 정보 검색 플랫폼

Cancer and Metastasis Reviews

Volumn 20, Issue 1-2, 2001, Pages 1-2

Molecular and physiologic mechanisms of drug resistance in cancer: An overview

(1) Kerbel, R S a

a SUNNYBROOK RESEARCH INSTITUTE (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB;

CANCER; CANCER PATIENT; CANCER RESEARCH; CANCER RESISTANCE; CANCER SURVIVAL; CHRONIC MYELOID LEUKEMIA; EDITORIAL; GENE AMPLIFICATION; HUMAN; MOLECULAR BIOLOGY; PHENOTYPE; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; DRUG RESISTANCE, NEOPLASM; HUMANS; NEOPLASMS;

EID: 0035689719 PISSN: 01677659 EISSN: None Source Type: Journal
DOI: 10.1023/A:1013129128673 Document Type: Editorial

Times cited : (34)

References (11)

1
- 0035810147
- Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia
- (2001) N Engl J Med , vol.344 , pp. 1031-1037
- Druker, B.J.¹ Talpaz, M.² Resta, D.J.³ Peng, B.⁴ Buchdunger, E.⁵ Ford, J.M.⁶ Lydon, N.B.⁷ Kantarjian, H.⁸ Capdeville, R.⁹ Ohno-Jones, S.¹⁰ Sawyers, C.L.¹¹

2
- 0033987746
- Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia
- (2000) J Clin Invest , vol.105 , pp. 3-7
- Druker, B.J.¹ Lydon, N.B.²

3
- 0000244046
- Evaluation of the safety and efficacy of an oral molecularly-targeted therapy, STI571, in patients with unresectable or metastatic gastrointestinal stromal tumors (GISTs) expressing C-KIT (CD17)
- 1a2001(abstract)
- Proc. Am. Soc. Clin. Oncol.
- Blanke, C.D.¹ Von Mehren, M.² Joensuu, H.³ Roberts, P.J.⁴ Eisenberg, B.⁵ Heinrich, M.⁶ Druker, B.⁷ Tuveson, D.⁸ Dimitrijevic, S.⁹ Siberman, S.L.¹⁰ Demetri, G.D.¹¹

4
- 0007961641
- STI571, an active drug in metastatic gastrointestinal stromal tumors (GIST), an EORTC phase I study
- 2a2001 (abstract)
- Proc. Am. Soc. Clin. Oncol.
- Van Oosterman, A.T.¹ Judson, I.² Verwej, J.³ Paola, E.D.⁴ Van Glabbeke, M.⁵ Dimitrijevic, S.⁶ Nelsen, O.⁷

5
- 0035810148
- Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor
- (2001) N Engl J Med , vol.344 , pp. 1052-1056
- Joensuu, H.¹ Roberts, P.J.² Sarlomo-Rikala, M.³ Andersson, L.C.⁴ Tervahartiala, P.⁵ Tuveson, D.⁶ Silberman, S.⁷ Capdeville, R.⁸ Dimitrijevic, S.⁹ Druker, B.¹⁰ Demetri, G.D.¹¹

6
- 0030614893
- Interstitial pH and pO2 gradients in solid tumors in vivo: High-resolution measurements reveal a lack of correlation
- (1997) Nat Med , vol.3 , pp. 177-182
- Helmlinger, G.¹ Yuan, F.² Dellian, M.³ Jain, R.K.⁴

7
- 0035810142
- Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome
- (2001) N Engl J Med , vol.344 , pp. 1038-1042
- Druker, B.J.¹ Sawyers, C.L.² Kantarjian, H.³ Resta, D.J.⁴ Reese, S.F.⁵ Ford, J.M.⁶ Capdeville, R.⁷ Talpaz, M.⁸

8
- 0035800507
- Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification
- (2001) Science , vol.21
- Gorre, M.E.¹ Mohammed, M.² Ellwood, K.³ Hsu, N.⁴ Paquette, R.⁵ Rao, P.N.⁶ Sawyers, C.L.⁷

9
- 0035933754
- Cancer research. Why some leukemia cells resist STI-571
- (2001) Science , vol.292 , pp. 2231-2233
- Marx, J.¹

10
- 0035394833
- Acquired resistance to the antitumor effect of epidermal growth factor receptor-blocking antibodies in vivo: A role for altered tumor angiogenesis
- (2001) Cancer Res , vol.61 , pp. 5090-5101
- Viloria-Petit, A.¹ Crombet, T.² Jothy, S.³ Rak, J.⁴ Kerbel, R.S.⁵

11
- 0034684075
- Role of alpha1 acid glycoprotein in the in vivo resistance of human BCR-ABL(+) leukemic cells to the abl inhibitor STI571
- (2000) J Natl Cancer Inst , vol.92 , pp. 1641-1650
- Gambacorti-Passerini, C.¹ Barni, R.² Le Coutre, P.³ Zucchetti, M.⁴ Cabrita, G.⁵ Cleris, L.⁶ Rossi, F.⁷ Gianazza, E.⁸ Brueggen, J.⁹ Cozens, R.¹⁰ Pioltelli, P.¹¹ Pogliani, E.¹² Corneo, G.¹³ Formelli, F.¹⁴ D'Incalci, M.¹⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.